Also traded on the NASDAQ, Vical Incorporated researches and develops biopharmaceutical products based on patented DNA delivery technologies. Vical looked like it was at a low according to Figure 7.17, and had a below-average 52-week range. 5,000 shares were bought at 10:51am when the stock price was $3.31 a share, giving an investment of $16,550.00.